Hemostasis And Tissue Sealing Agents Market Is Projected To Grow Due To Increasing Ability In Preventing Blood Loss Till 2022: Grand View Research, Inc.
The global hemostasis and tissue sealing agents market is
expected to reach USD 7.4 billion by 2022, according to a new report by Grand
View Research Inc. The global hemostasis and tissue sealing agents market has
gained popularity over time due to its ability in preventing blood loss. Rapid
growth of minimal invasive technology and rising demand for faster recovery by
patients is expected to promote market growth over the forecast period.
According to the CDC,
approximately 150 million of American population is currently suffering with at
least one chronic condition, which leads to surgeries and even mortality at
times. An estimate over the rising incidence was made by the CDC, which
concluded that over 48% of the entire American population is expected to suffer
by chronic condition.
The demand for wound management
is expected to rise with increasing chronic disease incidence over the next
seven years. The Public Health Agency of Canada in its report stated that the
chronic disease occurrence rate is anticipated to increase by 14% annually and
four out of five cases are of high risk requiring immediate treatment and
surgeries.
Browse full research report on Hemostasis And Tissue
Sealing Agents Market: http://www.grandviewresearch.com/industry-analysis/hemostasis-tissue-sealing-agents-market
Further key findings from the report suggest:
- The hemostats market is expected to grow at a CAGR of
over9.0% over the forecast period owing to, the rise in global volume of
surgeries and increased applicability across a variety of surgeries. The
products avoid occurrence of hypovolemic shock, thrombocytopenia, blood
transfusions, and increase in post-operative complications.
- Flowable hemostats are a combination of active and
mechanical agents. They function by blocking blood flow and also convert
fibrinogen into fibrin for the coagulation process to commence. This
segment is expected to grow at a lucrative CAGR of over 10.0% from 2015 to
2022.
- North America is estimated to be the largest market
for the hemostasis and tissue sealing agents over the forecast period and
is expected to account for over 30.0% share by 2022.
- Asia Pacific is identified as a lucrative market due
to a rapid growth in the surgery volume brought about by the introduction
of medical tourism. It is anticipated to account for over 27.0% of the
overall market share by 2022. The Europe hemostasis and tissue sealing
agents market is expected to be driven by the rise in geriatric population
base, which is expected to ultimately lead to a surge in procedure volume.
- Some key players of this market include Johnson &
Johnson, CryoLife Inc, Pfizer, C R Bard, B Braun, Covidien, and Smith
& Nephew.
- Market participants are involved in technological
advancements in order to ensure sustainability and improve regional
presence.
- For instance, in March 2015, Ethicon announced higher
efficiency of EVARREST fibrin sealant patch as compared to its substitute,
TachoSil patch (Baxter). Further study would be conducted at the St.
Vincent Heart Centre of Indiana to understand added advantages that the
product can offer.
- In August 2015, Integra Life Sciences announced a new
application of the Integra Dermal Regeneration Template in chronic
diabetes-based foot ulcers. The product is expected to be used for
treating these ulcers post its approval by the FDA in 2016.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global hemostasis and
tissue sealing agents market on the basis of product and region:
Hemostasis and Tissue Sealing Agents Product Outlook
(Revenue, USD Million, 2012 - 2022)
- Topical
hemostats
- Active
- Mechanical
- Flowable
- Tissue
sealing Agents
- Natural
- Synthetic
- Adhesion
barrier products
Hemostasis and Tissue Sealing Agents Regional Outlook
(Revenue, USD Million, 2012 - 2022)
- North
America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Asia
Pacific
- Japan
- China
- India
- Latin
America
- Brazil
- MEA
- South
Africa
Access Press Release
By Grand View Research: http://www.grandviewresearch.com/press-release/global-hemostasis-tissue-sealing-agents-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
Comments
Post a Comment